| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3570fbc10461e10753ee644f6b5eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b425ad92f4f61d5d745429607b9cf45b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4df40bca3cd1de348de19eb9cb2eadf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76217ff168edbb4f6e525167274c59ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09921edd2934f664354b4a3e90a327b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7461040ced6f74bd31456070fcd555d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2007-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbbbeca5ea01a56e81e2cfa48da8462c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006682873b41eb54f91ccaaedf1dc3df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c53f03f9e2cd3a85ee3f24f2b8b21d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4db7cb242a1a3da6a37e42ddf91a310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_240a0949749bcddd700790338c514268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a631d3965f38e19ce33659267be681 |
| publicationDate |
2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008064031-A9 |
| titleOfInvention |
Potent activation of antigen presenting cells by the hepatitis a virus cellular receptor 1 and its role in the regulation of immune responses |
| abstract |
The present invention relates to the identification of IgA? as a ligand for HAVCR1/TIM1, the receptor for Hepatitis A Virus. The invention provides compositions for inhibiting or promoting this interaction, and methods for influencing immunologic responses to antigens by administration of compounds that affect binding of IgA? to HAVCR1/TIM1. |
| priorityDate |
2006-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |